NTRK2 and cancer: TRKB and its ligand, brain-derived neurotrophic factor (BDNF), are highly expressed and associated with poor survival in various cancer types, including breast cancer9, colon cancer10, lung cancer11, pancreatic cancer12, ovarian cancer13, and oral squamous cell carcinoma (OSCC)14.